Chow, Robert – Trademark Portfolio
Entity Type: 01
Chow, Robert holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include STEMCYTE. The owner is based in Monrovia, CA.
1946 South Myrtle Avenue
Monrovia, CA 91016
Showing of trademarks Trademarks
Trademark Classifications
Chow, Robert's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Chow, Robert have?
Chow, Robert has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 2 cancelled.
What trademark classes does Chow, Robert file in?
Chow, Robert files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Chow, Robert's most well-known trademarks?
Chow, Robert's registered trademark portfolio includes well-known marks such as STEMCYTE. These are among 2 currently registered trademarks in the portfolio.
What is Chow, Robert's trademark registration success rate?
Chow, Robert has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.